Pharmaceutical giant Pfizer says its experimental antiviral COVID-19 pill has produced positive trial results. The drugmaker says it hopes to get regulatory approval for the easy-to-use drug in weeks or months.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3